Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

4.06USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$4.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,189
52-wk High
$4.50
52-wk Low
$2.95

About

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $88.11
Shares Outstanding(Mil.): 21.70
Dividend: --
Yield (%): --

Financials

  BCLI.OQ Industry Sector
P/E (TTM): -- 96.93 34.10
EPS (TTM): -0.81 -- --
ROI: -462.93 7.71 12.64
ROE: -801.78 8.16 17.18

Earnings vs. Estimates